-apine
Drugs with a three-ring core, many of them antipsychotics.
- Drugs ending in -apine: 13
- Approved somewhere: 10
- With a US drug page: 6
- Stem
- -apine
- Class
- Drugs with a three-ring core, many of them antipsychotics
- Sub-stem of
- -pin(e): Drugs with a three-ring core
- Most common targets
- HTR2A (7), HTR2C (5), DRD2 (3), Adrenergic receptor alpha-2 (2), D2-like dopamine receptor (2), SLC6A4 (1), SLC6A2 (1), Dopamine receptor (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -apine, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Amoxapine | Approved | SLC6A4, SLC6A2, Dopamine receptor | Serotonin transporter inhibitor |
| Clozapine | Approved | HTR2A, DRD2 | Serotonin 2a (5-HT2a) receptor antagonist |
| Mirtazapine | Approved | HTR2A, HTR2C, Adrenergic receptor alpha-2 | Serotonin 2a (5-HT2a) receptor antagonist |
| Nevirapine | Approved | POL | Human immunodeficiency virus type 1 reverse transcriptase inhibitor |
| Olanzapine | Approved | HTR2A, HTR2C, D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor antagonist |
| Quetiapine | Approved | HTR2A, HTR2C, DRD2 | Serotonin 2a (5-HT2a) receptor antagonist |
| Asenapine | Approved | DRD2, HTR2A | Dopamine D2 receptor antagonist |
| Clothiapine | Approved | Serotonin 2 (5-HT2) receptor, DRD4, Serotonin 3 (5-HT3) receptor | Serotonin 2 (5-HT2) receptor antagonist |
| Loxapine | Approved | HTR2A, HTR2C, D2-like dopamine receptor | Serotonin 2a (5-HT2a) receptor antagonist |
| Noscapine | Approved | — | — |
| Esmirtazapine | Phase 3 | HRH1, HTR2A, HTR2C, Adrenergic receptor alpha-2 | Histamine H1 receptor antagonist |
| Zicronapine | Phase 3 | — | — |
| Triapine | Phase 2 | RRM1, RRM2B | Ribonucleotide reductase inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO